BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3075839)

  • 1. New concepts of the growth spurt of puberty.
    Stanhope R; Preece MA; Grant DB; Brook CG
    Acta Paediatr Scand Suppl; 1988; 347():30-7. PubMed ID: 3075839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GH/IGF-I axis in puberty.
    Loche S; Casini MR; Faedda A
    Br J Clin Pract Suppl; 1996 Aug; 85():1-4. PubMed ID: 8995016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height after combined growth hormone and GnRH analogue treatment in adopted girls with early puberty.
    Tuvemo T; Jonsson B; Gustafsson J; Albertsson-Wikland K; Aronson AS; Häger A; Ivarson S; Kriström B; Marcus C; Nilsson KO; Westgren U; Westphal O; Aman J; Proos LA
    Acta Paediatr; 2004 Nov; 93(11):1456-62. PubMed ID: 15513572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precocious puberty and statural growth.
    Carel JC; Lahlou N; Roger M; Chaussain JL
    Hum Reprod Update; 2004; 10(2):135-47. PubMed ID: 15073143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of short stature with GnRH agonist and co-treatment with growth hormone: a controversial issue.
    Carel JC
    Mol Cell Endocrinol; 2006 Jul; 254-255():226-33. PubMed ID: 16787697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced growth hormone secretion prolongs puberty but does not delay the developmental increase in luteinizing hormone in the absence of gonadal negative feedback.
    Wilson ME; Chikazawa K; Fisher J; Mook D; Gould KG
    Biol Reprod; 2004 Aug; 71(2):588-97. PubMed ID: 15115727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation and evolution of organic central precocious puberty according to the type of CNS lesion.
    Trivin C; Couto-Silva AC; Sainte-Rose C; Chemaitilly W; Kalifa C; Doz F; Zerah M; Brauner R
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):239-45. PubMed ID: 16886967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth, growth hormone and sex steroid secretion in girls with central precocious puberty treated with a gonadotrophin releasing hormone (GnRH) analogue.
    Stanhope R; Pringle PJ; Brook CG
    Acta Paediatr Scand; 1988 Jul; 77(4):525-30. PubMed ID: 3293348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [True precocious puberty in non-tumor hydrocephalus. An analysis of 16 cases].
    Brauner R; Rappaport R; Nicod C; Malandry F; Thibaud E; Pierre-Kahn A; Renier D; Sainte-Rose C; Hirsch JF
    Arch Fr Pediatr; 1987; 44(6):433-6. PubMed ID: 3304186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of puberty in growth hormone deficient children.
    Saggese G; Federico G; Barsanti S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():329-34. PubMed ID: 10698597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GH and GHBP activity and not IGF-1 and its receptor activity express growth velocity reduction during treatment of central precocious puberty by a superactive GNRH analogue.
    Eshet R; Silbergeld A; Kauli R; Lazar L; Laron Z
    Isr J Med Sci; 1994 Aug; 30(8):592-5. PubMed ID: 8045738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The somatotropic axis in puberty.
    Brook CG; Hindmarsh PC
    Endocrinol Metab Clin North Am; 1992 Dec; 21(4):767-82. PubMed ID: 1486875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF; McNeill E; Young D; Donaldson MD
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK; Fan X; Tang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pubertal growth and growth hormone secretion.
    Martha PM; Reiter EO
    Endocrinol Metab Clin North Am; 1991 Mar; 20(1):165-82. PubMed ID: 2029886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mid-growth spurt--a pre-puberty growth spurt. Review of its significance and biological correlations].
    Mühl A; Herkner KR; Swoboda W
    Padiatr Padol; 1992; 27(5):119-23. PubMed ID: 1437227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.